Literature DB >> 15725647

Anticonvulsant hypersensitivity syndrome leading to reversible myocarditis.

Ali N Zaidi1.   

Abstract

A 67-year old Caucasian female was diagnosed with anticonvulsant hypersensitivity syndrome (AHS) after she developed the triad of high fevers, maculo-papular rash and internal organ involvement ten weeks after the institution of prophylactic phenytoin for resection of a meningioma. She developed congestive heart failure, with a substantial reduction in ejection fraction (EF) by an echocardiogram and serum cardiac enzyme elevation. In the setting of AHS, this was consistent with a drug-induced myocarditis. Treatment consisted of removal of the offending drug, diuretics and high dose steroids. Six weeks later her symptoms had completely resolved, with a return to a normal EF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15725647

Source DB:  PubMed          Journal:  Can J Clin Pharmacol        ISSN: 1198-581X


  4 in total

Review 1.  Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review.

Authors:  Ivan Gentile; Maria Talamo; Guglielmo Borgia
Journal:  BMC Infect Dis       Date:  2010-03-06       Impact factor: 3.090

2.  Type 1 diabetes mellitus in a child with phenobarbital hypersensitivity syndrome.

Authors:  C C Zou; L Liang; J F Fu
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

Review 3.  Myocarditis Associated with Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report and Review of the Literature.

Authors:  Daiki Morikawa; Eiji Hiraoka; Kotaro Obunai; Yasuhiro Norisue
Journal:  Am J Case Rep       Date:  2018-08-20

Review 4.  "Heart in DRESS": Cardiac Manifestations, Treatment and Outcome of Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Systematic Review.

Authors:  Milan Radovanovic; Djordje Jevtic; Andrew D Calvin; Marija Petrovic; Margaret Paulson; Libardo Rueda Prada; Lawrence Sprecher; Ivana Savic; Igor Dumic
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.